Ignite Creation Date:
2024-05-05 @ 5:09 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00390156
Status:
COMPLETED
Last Update Posted:
2020-07-28
First Post:
2006-10-18
Brief Title:
Imatinib Bevacizumab and Cyclophosphamide in Patients With Refractory Metastatic Solid Tumors
Sponsor:
University of California San Francisco
Organization:
University of California San Francisco